BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1307 related articles for article (PubMed ID: 19725342)

  • 41. Dexamethasone Does Not Inhibit Sugammadex Reversal After Rocuronium-Induced Neuromuscular Block.
    Buonanno P; Laiola A; Palumbo C; Spinelli G; Servillo G; Di Minno RM; Cafiero T; Di Iorio C
    Anesth Analg; 2016 Jun; 122(6):1826-30. PubMed ID: 27028777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rocuronium duration of action under sevoflurane, desflurane or propofol anaesthesia.
    Maidatsi PG; Zaralidou AT; Gorgias NK; Amaniti EN; Karakoulas KA; Giala MM
    Eur J Anaesthesiol; 2004 Oct; 21(10):781-6. PubMed ID: 15678732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
    Mosing M; Auer U; West E; Jones RS; Hunter JM
    Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial.
    Putz L; Dransart C; Jamart J; Marotta ML; Delnooz G; Dubois PE
    J Clin Anesth; 2016 Dec; 35():107-113. PubMed ID: 27871505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Reversal of rocuronium-induced neuromuscular blockade with sugammadex in patients for cesarean delivery treated with magnesium sulfate].
    Sakurai Y; Uchida M; Aiba J; Mimura F; Yamaguchi M; Kakumoto M
    Masui; 2014 Mar; 63(3):315-9. PubMed ID: 24724442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.
    Sorgenfrei IF; Norrild K; Larsen PB; Stensballe J; Ostergaard D; Prins ME; Viby-Mogensen J
    Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
    Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Saline Flush After Rocuronium Bolus Reduces Onset Time and Prolongs Duration of Effect: A Randomized Clinical Trial.
    Ishigaki S; Masui K; Kazama T
    Anesth Analg; 2016 Mar; 122(3):706-711. PubMed ID: 26599796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maintenance and recovery characteristics after sevoflurane or propofol during ambulatory surgery in children with epidural blockade.
    Guard BC; Sikich N; Lerman J; Levine M
    Can J Anaesth; 1998 Nov; 45(11):1072-8. PubMed ID: 10021955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
    Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
    Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sugammadex at both high and low doses does not affect the depth of anesthesia or hemodynamics: a randomized double blind trial.
    Fassoulaki A; Chondrogiannis K; Staikou C
    J Clin Monit Comput; 2017 Apr; 31(2):297-302. PubMed ID: 26894591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia.
    Amin AM; Mohammad MY; Ibrahim MF
    Middle East J Anaesthesiol; 2009 Feb; 20(1):39-51. PubMed ID: 19266825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function.
    Staals LM; Snoeck MM; Driessen JJ; Flockton EA; Heeringa M; Hunter JM
    Br J Anaesth; 2008 Oct; 101(4):492-7. PubMed ID: 18653492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
    Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
    Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reversal of rocuronium induced neuromuscular block with sugammadex in patients under 2 years of age. A series of 280 cases.
    Ozmete O; Dardag E; Civi S
    Ann Ital Chir; 2023; 94():612-616. PubMed ID: 38131376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block.
    Pavoni V; Gianesello L; Martinelli C; Horton A; Nella A; Gori G; Simonelli M; De Scisciolo G
    J Clin Anesth; 2016 Sep; 33():14-9. PubMed ID: 27555126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia.
    Kim KS; Cheong MA; Lee HJ; Lee JM
    Anesth Analg; 2004 Oct; 99(4):1080-1085. PubMed ID: 15385354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.